Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehuda Handelsman

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 13, 2016
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical TrialSultan Linjawi, Bruce W Bode, Louis B Chaykin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 24, 2012
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of AtherosclerosisPaul S Jellinger, Donald A Smith, Adi E Mehta, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 17, 2018
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUSGeorge Grunberger, Yehuda Handelsman, Zachary T Bloomgarden, et al.
Journal of Diabetes and Its Complications|June 18, 2022
Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studiesYehuda Handelsman, T Jared Bunch, Helena W Rodbard, et al.
Diabetologia|April 7, 2019
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING studyRobert S Rosenson, Martha L Daviglus, Yehuda Handelsman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 18, 2012
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summaryPaul S Jellinger, Donald A Smith, Adi E Mehta, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2007
Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task ForcePaul S Jellinger, Jaime A Davidson, Lawrence Blonde, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 2, 2011
Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump managementGeorge Grunberger, Timothy Silleck Bailey, A Jay Cohen, et al.
Current Medical Research and Opinion|May 27, 2017
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapyYehuda Handelsman, Brett Lauring, Ira Gantz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 1, 2017
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASESVivian A Fonseca, Zachary T Bloomgarden, Samuel Dagogo-Jack, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 13, 2016
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical TrialSultan Linjawi, Bruce W Bode, Louis B Chaykin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 24, 2012
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of AtherosclerosisPaul S Jellinger, Donald A Smith, Adi E Mehta, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 17, 2018
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUSGeorge Grunberger, Yehuda Handelsman, Zachary T Bloomgarden, et al.
Journal of Diabetes and Its Complications|June 18, 2022
Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studiesYehuda Handelsman, T Jared Bunch, Helena W Rodbard, et al.
Diabetologia|April 7, 2019
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING studyRobert S Rosenson, Martha L Daviglus, Yehuda Handelsman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 18, 2012
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summaryPaul S Jellinger, Donald A Smith, Adi E Mehta, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2007
Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task ForcePaul S Jellinger, Jaime A Davidson, Lawrence Blonde, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 2, 2011
Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump managementGeorge Grunberger, Timothy Silleck Bailey, A Jay Cohen, et al.
Current Medical Research and Opinion|May 27, 2017
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapyYehuda Handelsman, Brett Lauring, Ira Gantz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 1, 2017
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASESVivian A Fonseca, Zachary T Bloomgarden, Samuel Dagogo-Jack, et al.
Pageof 16